Atlas Trials

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Clinical trial NCT00716976 · COMPLETED

Trial details

NCT number
NCT00716976
Sponsor
Children's Oncology Group
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Brain TumorCentral Nervous System TumorChildhood Germ Cell TumorExtragonadal Germ Cell TumorLiver CancerNeuroblastomaOtotoxicityOvarian CancerSarcoma
Start date
2008-06-23
Primary completion
2015-04-09
Enrollment
131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.